From the Field
Artificial intelligence, health care, and energy transition: Three areas of focus for impact
How innovations in artificial intelligence, health care, and the energy transition can create value.
Hari Balkrishna, Portfolio Manager, Global Impact Equity Fund
Key Insights
  • Artificial intelligence (AI) can assist in reaching the targets set by the United Nations for their Sustainable Development Goals.
  • GLP‑1 drugs represent a watershed moment for the health care sector given their efficacy in treating both diabetes and obesity.
  • Energy transition extends beyond renewables, with many diverse types of companies helping in the pursuit of a net zero emissions world.

Get insights from our experts.

Subscribe to get email updates including article recommendations relating to global equities.

1 Source: IEA, Electricity 2024—Analysis and forecast to 2026. January 2024.

2 Source: Karagiannis, T., Bekiari, E. and Tsapas, A., 2023. Socioeconomic aspects of incretin‑based therapy. Diabetologia, 66(10), pp.1859–1868.

3 Net zero refers to a state where greenhouse gas emissions into the atmosphere are balanced by removals (such as through forests or carbon capture and storage).

Important Information

Call 1-800-225-5132 to request a prospectus or summary prospectus; each includes investment objectives, risks, fees, expenses, and other information you should read and consider carefully before investing.

This material is provided for informational purposes only and is not intended to be investment advice or a recommendation to take any particular investment action.

The views contained herein are those of the authors as of August 2024 and are subject to change without notice; these views may differ from those of other T. Rowe Price associates.

This information is not intended to reflect a current or past recommendation concerning investments, investment strategies, or account types, advice of any kind, or a solicitation of an offer to buy or sell any securities or investment services. The opinions and commentary provided do not take into account the investment objectives or financial situation of any particular investor or class of investor. Please consider your own circumstances before making an investment decision.

Information contained herein is based upon sources we consider to be reliable; we do not, however, guarantee its accuracy.

Past performance is not a reliable indicator of future performance. All investments are subject to market risk, including the possible loss of principal. All charts and tables are shown for illustrative purposes only.

Risks: The fund may not succeed in generating a positive environmental and/or social impact. The fund’s incorporation of environmental and/or social impact criteria into its investment process may cause the fund to perform differently from a fund that uses a different methodology to identify and/or incorporate environmental and/or social impact criteria or relies solely or primarily on financial metrics. International investments can be riskier than U.S. investments due to the adverse effects of currency exchange rates, differences in market structure and liquidity, as well as specific country, regional, and economic developments. Investments in emerging market countries are subject to greater risk and overall volatility than investments in the U.S. and developed markets. Health sciences firms are often dependent on government funding and regulation and are vulnerable to product liability lawsuits and competition from low‑cost generic product. Investing in technology stocks entails specific risks, including the potential for wide variations in performance and usually wide price swings, up and down.

T. Rowe Price Investment Services, Inc.

© 2024 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.

202407-3693749

Congratulations! You are now registered.

Start subscribing to receive email updates.

You have updated your email address.

An activation email has been sent to your new email address from T. Rowe Price.

Please click on the activation link in order to receive email updates.

You have an existing account

Click OK to view your subscriptions.

Preferred Website

Confirm

You are currently logged in to multiple T. Rowe Price websites.

You will need to log out below and log back in with your Advisor Dashboard credentials.

Log Out Now

You are now leaving the T. Rowe Price website.

T. Rowe Price is not responsible for the content of third party websites, including any performance data contained within them. Past performance cannot guarantee future results.

Cancel Go To Site